Exact Mass: 510.2832
Exact Mass Matches: 510.2832
Found 500 metabolites which its exact mass value is equals to given mass value 510.2832
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Physagulin A
Physagulin A is found in fruits. Physagulin A is a constituent of the famine food Physalis angulata (cutleaf ground cherry).
LysoPG(18:1(9Z)/0:0)
LysoPG(18:1(9Z)/0:0) is a lysophosphatidylglycerol. It is a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylglycerols can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPG(18:1(9Z)/0:0), in particular, consists of one chain of oleic acid at the C-1 position.
(2S,3S,4R)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid
Dodecyl-beta-D-maltoside
PA(2:0/18:1(12Z)-2OH(9,10))
PA(2:0/18:1(12Z)-2OH(9,10)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/18:1(12Z)-2OH(9,10)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 9,10-hydroxy-octadecenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
PA(18:1(12Z)-2OH(9,10)/2:0)
PA(18:1(12Z)-2OH(9,10)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(18:1(12Z)-2OH(9,10)/2:0), in particular, consists of one chain of one 9,10-hydroxy-octadecenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).
Schweinfurthin H
A stilbenoid isolated from Macaranga alnifolia and has been shwon to exhibit cytotoxic activity.
[1R-[1alpha(E),4beta,4abeta,5beta(E),6alpha,8aalpha]]-[4-(Acetyloxy)decahydro-6-hydroxy-1,4a,6-trimethyl-5-(3-methyl-2,4-pentadienyl)-1-naphthalenyl]methyl ester 3-(4-hydroxyphenyl)-2-propenoic acid
16-Diacetoxy-7alpha-hydroxy-18-malonyloxy-ent-cleroda-3-ene
[1R-[1alpha(Z),4beta,4abeta,5beta(E),6alpha,8aalpha]]-[4-(Acetyloxy)decahydro-6-hydroxy-1,4a,6-trimethyl-5-(3-methyl-2,4-pentadienyl)-1-naphthalenyl]methyl ester 3-(4-hydroxyphenyl)-2-propenoic acid
2-[(2R,4aS,8S,8aS)-8-[2-[(4aS,7R,8aR)-7-(1-carboxyethenyl)-1-hydroxy-4a-methyl-2-oxo-6,7,8,8a-tetrahydro-5H-naphthalen-1-yl]ethyl]-4a-methyl-7-oxo-1,2,3,4,8,8a-hexahydronaphthalen-2-yl]prop-2-enoic acid
(20R)-15alpha-hydroxy-8beta,9alpha,14alpha,17alpha-pregn-4-en-3-one 20-O-beta-D-glucopyranoside
(2beta,3beta,5beta,22R)-2,3,14,20,22,25-Hexahydroxy-6-oxocholest-7-en-26-oic acid
11-hydroxy-7Halpha,10Hbeta-eremophil-4(15)-ene 11-O-beta-D-(3-O,4-O,6-O-triacetyl)glucopyranoside
6beta-cinnamoyl--5alpha,7beta-dihydroxy-12,16-epoxy-12alpha-methoxycassa-13(15)-en-16-one|neocaesalpin G
24,25,26,27-tetranor-apotirucalla-(apoeupha)-1alpha-senecioyloxy-3alpha,7alpha-dihydroxy-14,20,22-trien-21,23-epoxy|meliacinolin
16beta-acetoxy-6alpha,7alpha-epoxy-5alpha-hydroxy-1-oxowitha-2,17(20),24-trienolide
3a-hydroxy-8-methyl-1,2,3,3a,8,8a-hexahydro-pyrrolo[2,3-b]indole-2-carboxylic acid 2-acetoxy-8a-hydroxy-5-isopropenyl-3,8-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl ester|fischerindoline
17-hydroxypregnanolone-glucuronide|O1-(17-hydroxy-20-oxo-5beta-pregnan-3alpha-yl)-beta-D-glucopyranuronic acid|O1-(17-Hydroxy-20-oxo-5beta-pregnan-3alpha-yl)-beta-D-glucopyranuronsaeure
5beta-myrtenyl-9alpha-hydroxy-4,5-dihydroatripliciolide-8-O-angelate
ent-15,16-trihydroxypimar-8(14)-en-3-yl beta-glucopyranoside-15,16-acetonide
His Gln Ala Arg
His Gln Val Lys
Zeylasterone
Zeylasterone is a natural product found in Maytenus woodsonii, Kokoona reflexa, and Celastrus paniculatus with data available.
[3-methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxobutan-2-yl] 2-hydroxy-3-methylpentanoate
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 9-methyldecanoate
2-[(2R,4aS,8S,8aS)-8-[2-[(4aS,7R,8aR)-7-(1-carboxyethenyl)-1-hydroxy-4a-methyl-2-oxo-6,7,8,8a-tetrahydro-5H-naphthalen-1-yl]ethyl]-4a-methyl-7-oxo-1,2,3,4,8,8a-hexahydronaphthalen-2-yl]prop-2-enoic acid
[3-methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxobutan-2-yl] 2-hydroxy-3-methylpentanoate [IIN-based: Match]
[3-methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxobutan-2-yl] 2-hydroxy-3-methylpentanoate [IIN-based on: CCMSLIB00000847843]
2-[(2R,4aS,8S,8aS)-8-[2-[(4aS,7R,8aR)-7-(1-carboxyethenyl)-1-hydroxy-4a-methyl-2-oxo-6,7,8,8a-tetrahydro-5H-naphthalen-1-yl]ethyl]-4a-methyl-7-oxo-1,2,3,4,8,8a-hexahydronaphthalen-2-yl]prop-2-enoic acid [IIN-based on: CCMSLIB00000845468]
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 9-methyldecanoate [IIN-based: Match]
2-[(2R,4aS,8S,8aS)-8-[2-[(4aS,7R,8aR)-7-(1-carboxyethenyl)-1-hydroxy-4a-methyl-2-oxo-6,7,8,8a-tetrahydro-5H-naphthalen-1-yl]ethyl]-4a-methyl-7-oxo-1,2,3,4,8,8a-hexahydronaphthalen-2-yl]prop-2-enoic acid [IIN-based: Match]
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 9-methyldecanoate [IIN-based on: CCMSLIB00000847198]
Ala His Lys Arg
Ala His Gln Arg
Ala His Arg Lys
Ala His Arg Gln
Ala Lys His Arg
Ala Lys Arg His
Ala Gln His Arg
Ala Gln Arg His
Ala Arg His Lys
Ala Arg His Gln
Ala Arg Lys His
Ala Arg Gln His
Glu His Ile Ile
Glu His Ile Leu
Glu His Leu Ile
Glu His Leu Leu
Glu Ile His Ile
Glu Ile His Leu
Glu Ile Ile His
Glu Ile Leu His
Glu Leu His Ile
Glu Leu His Leu
Glu Leu Ile His
Glu Leu Leu His
Phe Phe Val Val
Phe Val Phe Val
Phe Val Val Phe
His Ala Lys Arg
His Ala Gln Arg
His Ala Arg Lys
His Ala Arg Gln
His Glu Ile Ile
His Glu Ile Leu
His Glu Leu Ile
His Glu Leu Leu
His Ile Glu Ile
His Ile Glu Leu
His Ile Ile Glu
His Ile Lys Asn
His Ile Leu Glu
His Ile Asn Lys
His Ile Asn Gln
His Ile Gln Asn
His Lys Ala Arg
His Lys Ile Asn
His Lys Leu Asn
His Lys Asn Ile
His Lys Asn Leu
His Lys Gln Val
His Lys Arg Ala
His Lys Val Gln
His Leu Glu Ile
His Leu Glu Leu
His Leu Ile Glu
His Leu Lys Asn
His Leu Leu Glu
His Leu Asn Lys
His Leu Asn Gln
His Leu Gln Asn
His Asn Ile Lys
His Asn Ile Gln
His Asn Lys Ile
His Asn Lys Leu
His Asn Leu Lys
His Asn Leu Gln
His Asn Gln Ile
His Asn Gln Leu
His Gln Ile Asn
His Gln Lys Val
His Gln Leu Asn
His Gln Asn Ile
His Gln Asn Leu
His Gln Gln Val
His Gln Arg Ala
His Gln Val Gln
His Arg Ala Lys
His Arg Ala Gln
His Arg Lys Ala
His Arg Gln Ala
His Val Lys Gln
His Val Gln Lys
His Val Gln Gln
Ile Glu His Ile
Ile Glu His Leu
Ile Glu Ile His
Ile Glu Leu His
Ile His Glu Ile
Ile His Glu Leu
Ile His Ile Glu
Ile His Lys Asn
Ile His Leu Glu
Ile His Asn Lys
Ile His Asn Gln
Ile His Gln Asn
Ile Ile Glu His
Ile Ile His Glu
Ile Lys His Asn
Ile Lys Asn His
Ile Leu Glu His
Ile Leu His Glu
Ile Asn His Lys
Ile Asn His Gln
Ile Asn Lys His
Ile Asn Gln His
Ile Gln His Asn
Ile Gln Asn His
Lys Ala His Arg
Lys Ala Arg His
Lys His Ala Arg
Lys His Ile Asn
Lys His Leu Asn
Lys His Asn Ile
Lys His Asn Leu
Lys His Gln Val
Lys His Arg Ala
Lys His Val Gln
Lys Ile His Asn
Lys Ile Asn His
Lys Leu His Asn
Lys Leu Asn His
Lys Asn His Ile
Lys Asn His Leu
Lys Asn Ile His
Lys Asn Leu His
Lys Gln His Val
Lys Gln Val His
Lys Arg Ala His
Lys Arg His Ala
Lys Val His Gln
Lys Val Gln His
Leu Glu His Ile
Leu Glu His Leu
Leu Glu Ile His
Leu Glu Leu His
Leu His Glu Ile
Leu His Glu Leu
Leu His Ile Glu
Leu His Lys Asn
Leu His Leu Glu
Leu His Asn Lys
Leu His Asn Gln
Leu His Gln Asn
Leu Ile Glu His
Leu Ile His Glu
Leu Lys His Asn
Leu Lys Asn His
Leu Leu Glu His
Leu Leu His Glu
Leu Asn His Lys
Leu Asn His Gln
Leu Asn Lys His
Leu Asn Gln His
Leu Gln His Asn
Leu Gln Asn His
Asn His Ile Lys
Asn His Ile Gln
Asn His Lys Ile
Asn His Lys Leu
Asn His Leu Lys
Asn His Leu Gln
Asn His Gln Ile
Asn His Gln Leu
Asn Ile His Lys
Asn Ile His Gln
Asn Ile Lys His
Asn Lys His Ile
Asn Lys His Leu
Asn Lys Ile His
Asn Lys Leu His
Asn Leu His Lys
Asn Leu Lys His
Gln Ala His Arg
Gln Ala Arg His
Gln His Ala Arg
Gln His Lys Val
Gln His Arg Ala
Gln His Val Lys
Gln Lys His Val
Gln Lys Val His
Gln Arg Ala His
Gln Arg His Ala
Gln Val His Lys
Gln Val Lys His
Arg Ala His Lys
Arg Ala His Gln
Arg Ala Lys His
Arg Ala Gln His
Arg His Ala Lys
Arg His Ala Gln
Arg His Lys Ala
Arg His Gln Ala
Arg Lys Ala His
Arg Lys His Ala
Arg Gln Ala His
Arg Gln His Ala
Val Phe Phe Val
Val Phe Val Phe
Val His Lys Gln
Val His Gln Lys
Val Lys His Gln
Val Lys Gln His
Val Gln His Lys
Val Gln Lys His
Val Val Phe Phe
PG(18:1/0:0)[U]
PG(18:1/0:0)
Leukotriene D4 methyl ester
Physagulin A
Dodecyl-beta-D-maltoside
D013501 - Surface-Active Agents > D003902 - Detergents
Ethyl acrylate-acrylic acid-2-ethylhexyl acrylate-N-methylolacrylamide-acrylonitrile polymer
Atrasentan
C28313 - Endothelin Receptor Antagonist > C28334 - Endothelin Receptor Type A Antagonist D065128 - Endothelin Receptor Antagonists > D065130 - Endothelin A Receptor Antagonists D000970 - Antineoplastic Agents
N-(butoxymethyl)prop-2-enamide,ethyl prop-2-enoate,methyl 2-methylprop-2-enoate,2-methylprop-2-enenitrile,2-methylprop-2-enoic acid
(2S,3S,4R)-4-(1,3-Benzodioxol-5-yl)-1-[2-(dibutylamino)-2-oxoethyl]-2-(4-methoxyphenyl)pyrrolidine-3-carboxylic acid
(5R)-2,5,6-trihydroxy-2-methyl-6-[(2S,3R,5R,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-6-oxo-2,3,4,5,9,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]heptanoic acid
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (E)-octadec-11-enoate
Longirostrerone B
An azaphilone that is 7,8-dihydro-6H-isochromen-6-one substituted by a hydroxy group at position 7, a 4-hydroxy-2-methyl-6-oxocyclohexyl group at position 3, a methyl group at position 7 and a 5,7,9-trimethyl-2-oxoundeca-3,5-dien-1-yl group at position 8. Isolated from Chaetomium longirostre, it exhibits cytotoxic and antimalarial activities.
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[(4R,7R,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4R,7S,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4S,7R,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
[3-Methyl-1-[3-methyl-1-oxo-1-(2,3,4,5,6-pentahydroxyhexoxy)pentan-2-yl]oxy-1-oxobutan-2-yl] 2-hydroxy-3-methylpentanoate
1-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-methoxyphenyl)urea
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-oxanecarboxamide
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methyl-5-phenyl-3-isoxazolecarboxamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[1-oxo-2-(2-pyridinyl)ethyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[1-oxo-2-(3-pyridinyl)ethyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7S,8S)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4S,7R,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4R,7R,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4S,7S,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(4R,7S,8R)-5-[2-(dimethylamino)-1-oxoethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
[(2R,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methyl 9-methyldecanoate
methyl 6-O-[15-(ethyldisulfanyl)pentadecanoyl]-beta-D-galactoside
[3-[[(2S)-2,3-Dihydroxypropoxy]-hydroxyphosphoryl]oxy-2-hydroxypropyl] (E)-octadec-9-enoate
(2S)-3-({[(2S)-2,3-dihydroxypropoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropyl (9Z)-octadec-9-enoate
(2S)-1-({[(2S)-2,3-dihydroxypropoxy](hydroxy)phosphoryl}oxy)-3-hydroxypropan-2-yl (9Z)-octadec-9-enoate
(2R)-1-({[(2R)-2,3-dihydroxypropoxy](hydroxy)phosphoryl}oxy)-3-hydroxypropan-2-yl (9Z)-octadec-9-enoate
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-octadec-9-enoate
[(2R)-2-(5-hydroxypentanoyloxy)-3-phosphonooxypropyl] hexadecanoate
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-octadec-9-enoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (Z)-tetradec-9-enoate
[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-tridec-9-enoate
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (Z)-pentadec-9-enoate
[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-tridec-9-enoate
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-pentadec-9-enoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-tetradec-9-enoate
1-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1-sn-glycerol)
nebramycin 5
A carbamoylkanamycin that is tobramycin bearing a single carbamoyl substituent located at position 6 (on the 3-aminoglucose ring).
(3r,4r,4's,6r,6''s,9s,9''s,9ar,9''ar)-6,6''-bis(furan-3-yl)-9,9''-dimethyl-hexadecahydrodispiro[quinolizine-3,2'-thiolane-4',3''-quinolizin]-4-ol
(1s,2r,4r,6s,7s,10r,11r,16r,17r,18s)-18-(acetyloxy)-6-(furan-3-yl)-1,7,11,15,15-pentamethyl-14-oxo-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadec-12-en-17-yl acetate
2-[(2-{[2-(2-amino-n,3-dimethylbutanamido)-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-4-methylpentylidene)amino]benzoic acid
(2s,5z)-2-methyl-4-oxo-6-[(1r,3r,5s,10s,14r,15r,18r)-6,6,10,14,18-pentamethyl-7,13,17-trioxo-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadec-11-en-15-yl]hept-5-enoic acid
(6bs,8as,11r,12ar,12bs,14ar)-2,3-dihydroxy-11-(methoxycarbonyl)-6b,8a,11,12b,14a-pentamethyl-5-oxo-7,8,9,10,12,12a,13,14-octahydropicene-4-carboxylic acid
2-{[(2s)-2-{[(2r)-2-[(2s,3r)-2-amino-n,3-dimethylpentanamido]-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-3-methylbutylidene]amino}benzoic acid
(1s,2r,7s,9r,11r,12r,13s,16r)-15-[(1s)-1-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-12-hydroxy-2,16-dimethyl-3-oxo-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadeca-4,14-dien-13-yl acetate
(2e,5r)-5-{[(8r)-7-hydroxy-2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-6-[(2r)-2-methylbutanoyl]-5-oxochromen-8-yl]methyl}-2,6-dimethylhepta-2,6-dienoic acid
(1r,2r,4s,10s,11r,13s,14r,19r)-1,11-dihydroxy-9,9,14-trimethyl-17-[(1r)-1-[(2r)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-18-methylidene-3,8-dioxapentacyclo[11.7.0.0²,⁴.0⁴,¹⁰.0¹⁴,¹⁹]icosa-5,16-dien-7-one
(3r,4s,4'r,6s,6''s,9r,9''r,9as,9''as)-6,6''-bis(furan-3-yl)-9,9''-dimethyl-hexadecahydrodispiro[quinolizine-3,2'-thiolane-4',3''-quinolizin]-4-ol
(2r)-2-{[(2s)-2-{[(2r)-2-{[(2s)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-1-hydroxy-3-methylbutylidene]amino}-1-hydroxy-3-methylbutylidene]amino}-3-phenylpropanoic acid
3-(4-{3-hydroxy-3a,6,6,9a,11a-pentamethyl-4,7,10-trioxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}furan-2-yl)-2-methylpropanoic acid
5-{[7-hydroxy-2,2-dimethyl-8-(3-methylbut-2-en-1-yl)-6-(2-methylbutanoyl)-5-oxochromen-8-yl]methyl}-2,6-dimethylhepta-2,6-dienoic acid
(2'r,4's,6'r,8''r)-5''-(2-hydroxyethyl)-2',8''-bis(hydroxymethyl)-4'-methoxy-2',4',6'',8''-tetramethyl-1',3',3'',4'',7'',9''-hexahydrodispiro[cyclopropane-1,5'-indene-6',2''-indeno[4,5-b]pyran]-7'-one
(3e,5e,7s,8r,10s,15r,16z,18z,24s)-11-ethyl-7,20,24,27,28-pentahydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.0⁸,¹⁵.0⁹,¹³]octacosa-1(28),3,5,16,18,20,26-heptaen-2-one
(1e,3z,5z,7s,8r,9s,10s,11s,13r,15s,16z,18z,24s,25s)-11-ethyl-2,7,20,24,27-pentahydroxy-10-methyl-21,26-diazatetracyclo[23.2.1.0⁸,¹⁵.0⁹,¹³]octacosa-1,3,5,16,18,20,26-heptaen-28-one
[(1r,4r,4as,5r,6r,8as)-4-(acetyloxy)-6-hydroxy-1,4a,6-trimethyl-5-[(2e)-3-methylpenta-2,4-dien-1-yl]-hexahydro-2h-naphthalen-1-yl]methyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate
methyl (2s,4as,6ar,12br,14as,14br)-9-formyl-10,11-dihydroxy-2,4a,6a,12b,14a-pentamethyl-3,8-dioxo-4,5,6,6b,7,13,14,14b-octahydro-1h-picene-2-carboxylate
6-hydroxythiobinupharidine
{"Ingredient_id": "HBIN012470","Ingredient_name": "6-hydroxythiobinupharidine","Alias": "NA","Ingredient_formula": "C30H42N2O3S","Ingredient_Smile": "CC1CCC(N2C1CCC3(C2)CC4(CCC5C(CCC(N5C4O)C6=COC=C6)C)SC3)C7=COC=C7","Ingredient_weight": "510.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "19420;19421;19422","PubChem_id": "9936153","DrugBank_id": "NA"}
6-hydroxythionuphlutine b
{"Ingredient_id": "HBIN012471","Ingredient_name": "6-hydroxythionuphlutine b","Alias": "NA","Ingredient_formula": "C30H42N2O3S","Ingredient_Smile": "CC1CCC(N2C1CCC3(C2)CC4(CCC5C(CCC(N5C4O)C6=COC=C6)C)SC3)C7=COC=C7","Ingredient_weight": "510.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "19424;19425;19426","PubChem_id": "10984042","DrugBank_id": "NA"}
6'-hydroxythionuphlutine b
{"Ingredient_id": "HBIN012472","Ingredient_name": "6'-hydroxythionuphlutine b","Alias": "NA","Ingredient_formula": "C30H42N2O3S","Ingredient_Smile": "CC1CCC(N2C1CCC3(C2)CC4(CCC5C(CCC(N5C4O)C6=COC=C6)C)CS3)C7=COC=C7","Ingredient_weight": "510.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "19423","PubChem_id": "10164525","DrugBank_id": "NA"}
applanoxidic acid F
{"Ingredient_id": "HBIN016523","Ingredient_name": "applanoxidic acid F","Alias": "NA","Ingredient_formula": "C30H38O7","Ingredient_Smile": "CC(CC(=O)C=C(C)C1CC(=O)C2(C1(C(=O)C=C3C24C(O4)CC5C3(CCC(=O)C5(C)C)C)C)C)C(=O)O","Ingredient_weight": "510.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38765","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101664507","DrugBank_id": "NA"}